FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/30/2026
Back to search
Official data from USPTO
INDIVUMED THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
06/30/2026
Trademark type
Combined
Nice classes
5, 9, 42, 44
Filing date
02/22/2024
Registration date
03/31/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/31/2026
Last transaction
06/30/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
27
Owner location
DE
Examiner
SEVERSON, JUSTIN
Law office
M20
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the term "INDIVUMED" in blue letters above the term "THERAPEUTICS" in smaller blue letters. To the left of the terms is a design of a blue circle with a smaller red circle overlaying the topright portion, there is a white space between the circles.
Holders and representatives
Holders
Indivumed GmbH
Representatives
R. Glenn Schroeder Schroeder Law PC
Technical classification
Nice Classes
Class 5Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticaltherapeutic and veterinary preparationsin particular medicines for human beings and animals for the treatment of cancermetabolic diseasescardiovascular diseasesinflammatory diseasesdiseases of the immune system; human and animal sample materialsfor medical purposesAllograft or Xenograft tissue preparationstissue cutsblood plasmablood serumascitescerebrospinal fluidhuman and animal urine and human and animal stool; test kits of human and animal samples materials for medical purposes comprising medical diagnostic reagents for medical diagnostic purposes; therapeutic preparations for the treatment of cancermetabolic diseasescardiovascular diseasesinflammatory diseasesdiseases of the immune systemmade using molecular biologicalmolecular geneticgenetic engineeringimmunological and biotechnical methods; medical diagnostic reagents; clinical diagnostic reagents for medical use; medical diagnostic test strips for blood analysis and urine analysis; diagnostic preparations and materials for medical or veterinary purposes; diagnostic reagents for medical use; diagnostic substances for medical use; biological material collectionsbiological tissue samplesblood plasma samples and blood serum samples for medical purposes; cancer material collectionsbiological tissue samplesblood plasma samples and blood serum samples for cancer diagnosis and treatment purposes; medical sample collections; biological sample collectionsbiological tissue samplesblood plasma samples and blood serum samples for medical purposes; biopsy material collectionsbiological tissue samples; all the afore-mentioned in particular with regard to the field of oncology
Class 9
Apparatus and instruments for scientific research in laboratoriesin particular apparatus for analysis of biologic samples and for the qualitative and quantitative recognition of analytes in samplesthe identification of sample typeselectronic analysers and analysers for the qualitative and quantitative recognition of samples and identification of the sample type and molecular states; apparatus for the typing of tissues and tissue samplesnamely for the molecular analysis of biological samples such as tissuecutsbloodserumplasmaascitescerebrospinal fluidurine or stool; apparatus for recordingtransmission or reproduction of datahard disk drivesblank hard computer discssolid-state drivesUSB hardware; blank magnetic data carriersdata processing equipment and computers
Class 42
Scientific and technological servicesscientific research and design for others in the field of cancermetabolic diseasescardiovascular diseasesinflammatory diseasesdiseases of the immune system; research services in the field of cancermetabolic diseasescardiovascular diseasesinflammatory diseasesdiseases of the immune system; design and development of computer hardware and softwarein particular computer programs; scientific research for medical purposesin particular molecular biologicalimmunological and histological laboratory servicesin particular research and development in the field of human medical and veterinary medical diagnostics and therapy; typing of tissue and tissue samplesin particular using molecular biologicalimmunologicalgenetic engineering and histological methods for research purposes; collection of human and animal biospecimen and clinical data for the diagnosis and treatment of cancermetabolic diseasescardiovascular diseasesinflammatory diseasesdiseases of the immune system; generation ofby means of scientific computer-aided sample analysisprovision ofby means of cloud storage and online access of multi-omics data from human and animal biospecimenin particular genomicepigenomicproteomicphosphorproteomicRNAtranscriptomiclipidomic and metabolomic data for the diagnosis and treatment of cancermetabolic diseasescardiovascular diseasesinflammatory diseasesdiseases of the immune system; medical research laboratory servicestyping of tissue and tissue samplesin particular using molecular biologicalimmunologicalgenetic engineering and histological methods; database design and development; providing online non-downloadable computer software platforms for hosting databases; installationmaintenance and updating of database software; providing scientific research information and results in the field of diagnosis and treatment of cancermetabolic diseasescardiovascular diseasesinflammatory diseasesdiseases of the immune system from an online searchable database; programming of databases; collecting geneticmedicalbiomedicalbiologicchemical and biochemical data and informationin particular information generated through the use of imaging techniquesthe use of liquid biopsy methodsthe use of histopathological analysis and proceduresthe use of genetic analysis and the use of genomicsproteomicstranscriptomicsmetabolomicslipidomics and/or glycomics studies and analysis for medical research; scientific and laboratory analysis using bioinformatics and computational biology in the field of diagnosis and treatment of cancermetabolic diseasescardiovascular diseasesinflammatory diseasesdiseases of the immune system; consultancy relating to research and development in the field of therapeutics and pharmaceutics; pharmaceutical and therapeutical products development; pharmaceutical research and development services; research and development for the pharmaceutical and biotechnological industry; services for research and development in the pharmaceutical and biotechnical field; services for research and development regarding pharmaceuticstherapeuticsdiagnosticsespecially for the medical examination and medical care of patients
Class 44
Medical analysis in connection with the treatment of individualsmedical analysis of X-rays and blood samplesmedical testing for diagnostic and treatment purposes; provision of analysis files which provide medical information to medical and scientific personnel and allows members to update their medical treatment or scientific research plans; medical clinic services; pharmaceutical advisory services; medical analysis services using bioinformatics and computational biologyfor patient diagnostic and treatment purposes; providing supporting services and advice to hospitals and other medical care centerscollecting and stabilizing of human and animal biospecimensthe collection of related clinical data for patient diagnostic and treatment purposes; all the afore-mentioned in particular with regard to the field of oncology
Publications
History of USPTO decisions and trademark events.
35 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/31/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
03/31/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/10/2026
PUBO
PUBLISHED FOR OPPOSITION
02/10/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/04/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/20/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
01/20/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/20/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
01/20/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/20/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/19/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
09/03/2025
GNFR
FINAL REFUSAL E-MAILED
09/03/2025
CNFR
FINAL REFUSAL WRITTEN
09/03/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/03/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/03/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/25/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/25/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/25/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/06/2025
GNRT
NON-FINAL ACTION E-MAILED
02/06/2025
CNRT
NON-FINAL ACTION WRITTEN
02/06/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/31/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/31/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/31/2024
RFNT
REFUSAL PROCESSED BY IB
10/19/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/27/2024
RFRR
REFUSAL PROCESSED BY MPU
09/27/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/25/2024
CNRT
NON-FINAL ACTION WRITTEN
09/24/2024
DOCK
ASSIGNED TO EXAMINER
09/11/2024
MAFR
APPLICATION FILING RECEIPT MAILED
04/12/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/08/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/04/2024
Continuous trademark protection
Get notified about every new filing that threatens INDIVUMED THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.